©The Author(s) 2026.
World J Cardiol. Jan 26, 2026; 18(1): 114108
Published online Jan 26, 2026. doi: 10.4330/wjc.v18.i1.114108
Published online Jan 26, 2026. doi: 10.4330/wjc.v18.i1.114108
Figure 4 Effects of nicotinamide adenine dinucleotide oxidized form on the expression of NOD-like receptor pyrin domain-containing 3, associated speck-like protein containing a CARD, and caspase-1, reverse transcription polymerase chain reaction was used to analyze the gene expression of NOD-like receptor pyrin domain-containing 3, associated speck-like protein containing a CARD, and caspase-1 (n = 5).
The normal group refers to H9c2 cells cultured in an incubator containing 21% oxygen and 5% CO2, and serves as the control group; the hypoxia/re-oxygenation (H/R) group refers to H9c2 cells subjected to an H/R process; the H/R + acetyl group refers to H9c2 cells cultured under an H/R procedure with acetylcysteine treatment; the H/R + nicotinamide adenine dinucleotide group refers to H9c2 cells cultured under an H/R procedure with nicotinamide adenine dinucleotide oxidized form (NAD+) treatment. NLRP3: NOD-like receptor pyrin domain-containing 3; H/R: Hypoxia/re-oxygenation; ASC: Associated speck-like protein containing a CARD; NAD: Nicotinamide adenine dinucleotide; NAD+: Nicotinamide adenine dinucleotide oxidized form.
- Citation: Dong S, Liu YQ, Tu YJ, Gao S, Liu YJ, Liu C, Pei ZW. Nicotinamide adenine dinucleotide inhibits the production of reactive oxygen species and myocardial cell pyroptosis caused by hypoxia/re-oxygenation injury. World J Cardiol 2026; 18(1): 114108
- URL: https://www.wjgnet.com/1949-8462/full/v18/i1/114108.htm
- DOI: https://dx.doi.org/10.4330/wjc.v18.i1.114108